96 related articles for article (PubMed ID: 16181099)
1. Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy.
Nico B; Roncali L; Mangieri D; Ribatti D
Curr Neurovasc Res; 2005 Jan; 2(1):47-54. PubMed ID: 16181099
[TBL] [Abstract][Full Text] [Related]
2. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
[TBL] [Abstract][Full Text] [Related]
3. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.
Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L
Neuroscience; 2006 Jul; 140(3):835-48. PubMed ID: 16650610
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
5. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse.
Nico B; Mangieri D; Crivellato E; Longo V; De Giorgis M; Capobianco C; Corsi P; Benagiano V; Roncali L; Ribatti D
Brain Pathol; 2007 Oct; 17(4):399-406. PubMed ID: 17784876
[TBL] [Abstract][Full Text] [Related]
6. Altered blood-brain barrier development in dystrophic MDX mice.
Nico B; Paola Nicchia G; Frigeri A; Corsi P; Mangieri D; Ribatti D; Svelto M; Roncali L
Neuroscience; 2004; 125(4):921-35. PubMed ID: 15120852
[TBL] [Abstract][Full Text] [Related]
7. Brain function in Duchenne muscular dystrophy.
Anderson JL; Head SI; Rae C; Morley JW
Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
[TBL] [Abstract][Full Text] [Related]
8. What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?
Manning J; O'Malley D
J Muscle Res Cell Motil; 2015 Apr; 36(2):155-67. PubMed ID: 25669899
[TBL] [Abstract][Full Text] [Related]
9. α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice.
Annese T; Ruggieri S; De Giorgis M; Ribatti D; Tamma R; Nico B
Brain Res Bull; 2019 Apr; 147():69-77. PubMed ID: 30711624
[TBL] [Abstract][Full Text] [Related]
10. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
Bozycki L; Łukasiewicz K; Matryba P; Pikula S
Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
[TBL] [Abstract][Full Text] [Related]
11. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
[TBL] [Abstract][Full Text] [Related]
12. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
14. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.
Wang Q; Wang W; Wang G; Rodney GG; Wehrens XH
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):177-84. PubMed ID: 26555638
[TBL] [Abstract][Full Text] [Related]
16. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
17. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
Terrill JR; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
[TBL] [Abstract][Full Text] [Related]
18. Early alterations of the behavioural structure of mice affected by Duchenne muscular dystrophy and tested in open-field.
Casarrubea M; Faulisi F; Raso G; Aiello S; Crescimanno G
Behav Brain Res; 2020 May; 386():112609. PubMed ID: 32194185
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
20. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
